| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.001 |